Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval
Titel:
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval
Auteur:
Kaye, S.B. Colombo, N. Monk, B.J. Tjulandin, S. Kong, B. Roy, M. Chan, S. Filipczyk-Cisarz, E. Hagberg, H. Vergote, I. Lebedinsky, C. Parekh, T. Santabárbara, P. Park, Y.C. Nieto, A. Poveda, A.